Functional nucleotide sequences capable of promoting non-viral genetic transfer

Non-viral Gene Therapy: Gene Design and Delivery

Volumn , Issue , 2005, Pages 198-210

  Mazda, Osam ^a   Kishida, Tsunao ^a,b  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b Louis Pasteur Center for Medical Research   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33847066907     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/4-431-27879-6_16     Document Type: Chapter

References (78)

1. Adams A (1987) Replication of latent Epstein-Barr virus genomes in Raji cells. J Virol 61:1743-1746
2. Ambinder RF, Mullen MA, Chang YN, Hayward GS, Hayward SD (1991) Functional domains of Epstein-Barr virus nuclear antigen EBNA-1. J Virol 65:1466-1478
3. Asada H, Kishida T, Hirai H, Satoh E, Ohashi S, Takeuchi M, Kubo T, Kita M, Iwakura Y, Imanishi J, Mazda O (2002) Significant antitumor effects obtained by autologous tumor cell vaccine engineered to secrete interleukin-12 (IL-12) and IL-18 by means of the EBV/lipoplex. Mol Ther 5:609-616
4. Belur LR, Frandsen JL, Dupuy AJ, Ingbar DH, Largaespada DA, Hackett PB, Scott McIvor R (2003) Gene insertion and long-term expression in lung mediated by the Sleeping Beauty transposon system. Mol Ther 8:501-507
5. Black J, Vos JM (2002) Establishment of an oriP/EBNA1-based episomal vector transcribing human genomic beta-globin in cultured murine fibroblasts. Gene Ther 9:1447-1454
6. Cui FD, Kishida T, Ohashi S, Asada H, Yasutomi K, Satoh E, Kubo T, Fushiki S, Imanishi J, Mazda O (2001) Highly efficient gene transfer into murine liver achieved by intravenous administration of naked Epstein-Barr virus (EBV)-based plasmid vectors. Gene Ther 8:1508-1513
7. Cui FD, Asada H, Kishida T, Itokawa Y, Nakaya T, Ueda Y, Yamagishi H, Gojo S, Kita M, Imanishi J, Mazda O (2003) Intravascular naked DNA vaccine encoding glycoprotein B induces protective humoral and cellular immunity against herpes simplex virus type 1 infection in mice. Gene Ther 10:2059-2066
8. Cui FD, Asada H, Jin ML, Kishida T, Shin-Ya M, Nakaya T, Kita M, Ishii M, Iwai M, Okanoue T, Imanishi J, Mazda O (2005) Cytokine genetic adjuvant facilitates prophylactic intravascular DNA vaccine against acute and latent herpes simplex virus infection in mice. Gene Ther 12:160-168
9. Cui Z, Mumper RJ (2003) Microparticles and nanoparticles as delivery systems for DNA vaccines. Crit Rev Ther Drug Carrier Syst 20:103-137
10. Dupuy AJ, Clark K, Carlson CM, Fritz S, Davidson AE, Markley KM, Finley K, Fletcher CF, Ekker SC, Hackett PB, Horn S, Largaespada DA (2002) Mammalian germ-line transgenesis by transposition. Proc Natl Acad Sci U S A 99:4495-4499
11. Felgner PL, Ringold GM (1989) Cationic liposome-mediated transfection. Nature 337:387-388
12. Fischer N, Kremmer E, Lautscham G, Mueller-Lantzsch N, Grasser FA (1997) Epstein-Barr virus nuclear antigen 1 forms a complex with the nuclear transporter karyopherin alpha2. J Biol Chem 272:3999-4005
13. Fischer SE, Wienholds E, Plasterk RH (2001) Regulated transposition of a fish transposon in the mouse germ line. Proc Natl Acad Sci U S A 98:6759-6764
14. Gahn TA, Sugden B (1995) An EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein-Barr virus LMP gene. J Virol 69:2633-2636
15. Haase SB, Calos MP (1991) Replication control of autonomously replicating human sequences. Nucleic Acids Res 19:5053-5058
16. Harada Y, Iwai M, Tanaka S, Okanoue T, Kashima K, Maruyama-Tabata H, Hirai H, Satoh E, Imanishi J, Mazda O (2000) Highly efficient suicide gene expression in hepatocellular carcinoma cells by Epstein-Barr virus-based plasmid vectors combined with polyamidoamine dendrimer. Cancer Gene Ther 7:27-36
17. Harris JW, Strong DD, Amoui M, Baylink DJ, Lau KH (2002) Construction of a Tc1-like transposon Sleeping Beauty-based gene transfer plasmid vector for generation of stable transgenic mammalian cell clones. Anal Biochem 310:15-26
18. Hebert E (2003) Improvement of exogenous DNA nuclear importation by nuclear localization signal-bearing vectors: a promising way for non-viral gene therapy? Biol Cell 95:59-68
19. Herweijer H, Wolff JA (2003) Progress and prospects: naked DNA gene transfer and therapy. Gene Ther 10:453-458
20. Hirai H, Satoh E, Osawa M, Inaba T, Shimazaki C, Kinoshita S, Nakagawa M, Mazda O, Imanishi J (1997) Use of EBV-based Vector/HVJ-liposome complex vector for targeted gene therapy of EBV-associated neoplasms. Biochem Biophys Res Commun 241:112-118
21. Horie K, Yusa K, Yae K, Odajima J, Fischer SE, Keng VW, Hayakawa T, Mizuno S, Kondoh G, Ijiri T, Matsuda Y, Plasterk RH, Takeda J (2003) Characterization of Sleeping Beauty transposition and its application to genetic screening in mice. Mol Cell Biol 23:9189-9207
22. Hosseinkhani H, Aoyama T, Ogawa O, Tabata Y (2003) Ultrasound enhances the transfection of plasmid DNA by non-viral vectors. Curr Pharm Biotechnol 4:109-122
23. Itokawa Y, Mazda O, Ueda Y, Kishida T, Asada H, Cui FD, Fuji N, Fujiwara H, Shin-Ya M, Yasutomi K, Imanishi J, Yamagishi H (2004) Interleukin-12 genetic administration suppressed metastatic liver tumor unsusceptible to CTL. Biochem Biophys Res Commun 314:1072-1079
24. Ivics Z, Izsvak Z (2004) Transposable elements for transgenesis and insertional mutagenesis in vertebrates: a contemporary review of experimental strategies. Methods Mol Biol 260:255-276
25. Ivics Z, Hackett PB, Plasterk RH, Izsvak Z (1997) Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell 91:501-510
26. Iwai M, Harada Y, Tanaka S, Muramatsu A, Mori T, Kashima K, Imanishi J, Mazda O (2002) Polyethylenimine-mediated suicide gene transfer induces a therapeutic effect for hepatocellular carcinoma in vivo by using an Epstein/Barr virus-based plasmid vector. Biochem Biophys Res Commun 291:48-54
27. Izsvak Z, Ivics Z (2004) Sleeping beauty transposition: biology and applications for molecular therapy. Mol Ther 9:147-156
28. Izsvak Z, Ivics Z, Plasterk RH (2000) Sleeping Beauty, a wide host-range transposon vector for genetic transformation in vertebrates. J Mol Biol 302:93-102
29. Jankelevich S, Kolman JL, Bodnar JW, Miller G (1992) A nuclear matrix attachment region organizes the Epstein-Barr viral plasmid in Raji cells into a single DNA domain. EMBO J 11:1165-1176
30. Kelleher ZT, Fu H, Livanos E, Wendelburg B, Gulino S, Vos JM (1998) Epstein-Barr-based episomal chromosomes shuttle 100 kb of self-replicating circular human DNA in mouse cells. Nat Biotechnol 16:762-768.
31. Kishida T, Asada H, Satoh E, Tanaka S, Shinya M, Hirai H, Iwai M, Tahara H, Imanishi J, Mazda O (2001) In vivo electroporation-mediated transfer of interleukin-12 and interleukin-18 genes induces significant antitumor effects against melanoma in mice. Gene Ther 8:1234-1240
32. Kishida T, Asada H, Itokawa Y, Cui FD, Shin-Ya M, Gojo S, Yasutomi K, Ueda Y, Yamagishi H, Imanishi J, Mazda O (2003a) Interleukin (IL)-21 and IL-15 genetic transfer synergistically augments therapeutic antitumor immunity and promotes regression of metastatic lymphoma. Mol Ther 8:552-558
33. Kishida T, Asada H, Itokawa Y, Yasutomi K, Shin-Ya M, Gojo S, Cui FD, Ueda Y, Yamagishi H, Imanishi J, Mazda O (2003b) Electrochemo-gene therapy of cancer: intratumoral delivery of interleukin-12 gene and bleomycin synergistically induced therapeutic immunity and suppressed subcutaneous and metastatic melanomas in mice. Mol Ther 8:738-745
34. Kukowska-Latallo JF, Bielinska AU, Johnson J, Spindler R, Tomalia DA, Baker JR, Jr. (1996) Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers. Proc Natl Acad Sci U S A 93:4897-4902
35. Kumar VV, Singh RS, Chaudhuri A (2003) Cationic transfection lipids in gene therapy: successes, set-backs, challenges and promises. Curr Med Chem 10:1297-1306
36. Lechardeur D, Lukacs GL (2002) Intracellular barriers to non-viral gene transfer. Curr Gene Ther 2:183-194
37. Lemkine GF, Demeneix BA (2001) Polyethylenimines for in vivo gene delivery. Curr Opin Mol Ther 3:178-182
38. Liu G, Aronovich EL, Cui Z, Whitley CB, Hackett PB (2004a) Excision of Sleeping Beauty transposons: parameters and applications to gene therapy. J Gene Med 6:574-583
39. Liu L, Sanz S, Heggestad AD, Antharam V, Notterpek L, Fletcher BS (2004b) Endothelial targeting of the Sleeping Beauty transposon within lung. Mol Ther 10:97-105
40. Maruyama-Tabata H, Harada Y, Matsumura T, Satoh E, Cui F, Iwai M, Kita M, Hibi S, Imanishi J, Sawada T, Mazda O (2000) Effective suicide gene therapy in vivo by EBV-based plasmid vector coupled with polyamidoamine dendrimer. Gene Ther 7:53-60
41. Mazda O (2000) Application of Epstein-Barr virus (EBV) and its genetic elements to gene therapy. In: Cid-Arregui A, Garcia-Carranca A (Eds) Viral Vectors: Basic Science and Gene Therapy. Eaton Publishing, Natick, MA. pp 325-337
42. Mazda O (2002) Improvement of non-viral gene therapy by Epstein-Barr virus (EBV) - based plasmid vectors. Curr Gene Ther 2:379-392
43. Mazda O, Satoh E, Yasutomi K, Imanishi J (1997) Extremely efficient gene transfection into lympho-hematopoietic cell lines by Epstein-Barr virus-based vectors. J Immunol Methods 204:143-151
44. Mikkelsen JG, Yant SR, Meuse L, Huang Z, Xu H, Kay MA (2003) Helper-Independent Sleeping Beauty transposon-transposase vectors for efficient non-viral gene delivery and persistent gene expression in vivo. Mol Ther 8:654-665
45. Montini E, Held PK, Noll M, Morcinek N, Al-Dhalimy M, Finegold M, Yant SR, Kay MA, Grompe M (2002) In vivo correction of murine tyrosinemia type I by DNA-mediated transposition. Mol Ther 6:759-769
46. Nakanishi H, Mazda O, Satoh E, Asada H, Morioka H, Kishida T, Nakao M, Mizutani Y, Kawauchi A, Kita M, Imanishi J, Miki T (2003) Non-viral genetic transfer of Fas ligand induced significant growth suppression and apoptotic tumor cell death in prostate cancer in vivo. Gene Ther 10:434-442
47. Niidome T, Huang L (2002) Gene therapy progress and prospects: non-viral vectors. Gene Ther 9:1647-1652
48. Ohashi S, Kubo T, Ikeda T, Arai Y, Takahashi K, Hirasawa Y, Takigawa M, Satoh E, Imanishi J, Mazda O (2001) Cationic polymer-mediated genetic transduction into cultured human chondrosarcoma-derived HCS-2/8 cells. J Orthop Sci 6:75-81
49. Ohashi S, Kubo T, Kishida T, Ikeda T, Takahashi K, Arai Y, Terauchi R, Asada H, Imanishi J, Mazda O (2002) Successful genetic transduction in vivo into synovium by means of electroporation. Biochem Biophys Res Commun 293:1530-1535
50. Ortiz-Urda S, Lin Q, Yant SR, Keene D, Kay MA, Khavari PA (2003) Sustainable correction of junctional epidermolysis bullosa via transposon-mediated non-viral gene transfer. Gene Ther 10:1099-1104
51. Plank C, Anton M, Rudolph C, Rosenecker J, Krotz F (2003) Enhancing and targeting nucleic acid delivery by magnetic force. Expert Opin Biol Ther 3:745-758
52. Puglielli MT, Woisetschlaeger M, Speck SH (1996) oriP is essential for EBNA gene promoter activity in Epstein-Barr virus-immortalized lymphoblastoid cell lines. J Virol 70:5758-5768
53. Raz E, Van Luenen HG, Schaerringer B, Plasterk RH, Driever W (1998) Transposition of the nematode Caenorhabditis elegans Tc3 element in the zebrafish Danio rerio. Curr Biol 8:82-88
54. Reisman D, Sugden B (1986) trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1. Mol Cell Biol 6:3838-3846
55. Roberg-Perez K, Carlson CM, Largaespada DA (2003) MTID: a database of Sleeping Beauty transposon insertions in mice. Nucleic Acids Res 31:78-81
56. Rocha A, Ruiz S, Coll JM (2002) Improvement of DNA transfection with cationic liposomes. J Physiol Biochem 58:45-56
57. Satoh E, Hirai H, Inaba T, Shimazaki C, Nakagawa M, Imanishi J, Mazda O (1998) Successful transfer of ADA gene in vitro into human peripheral blood CD34+ cells by transfecting EBV-based episomal vectors. FEBS Lett 441:39-42
58. Satoh E, Osawa M, Tomiyasu K, Hirai H, Shimazaki C, Oda Y, Nakagawa M, Kondo M, Kinoshita S, Mazda O, Imanishi J (1997) Efficient gene transduction by Epstein-Barrvirus-based vectors coupled with cationic liposome and HVJ-liposome. Biochem Biophys Res Commun 238:795-799
59. Sclimenti CR, Neviaser AS, Baba EJ, Meuse L, Kay MA, Calos MP (2003) Epstein-Barr virus vectors provide prolonged robust factor IX expression in mice. Biotechnol Prog 19:144-151
60. Stoll SM, Calos MP (2002) Extrachromosomal plasmid vectors for gene therapy. Curr Opin Mol Ther 4:299-305
61. Stoll SM, Sclimenti CR, Baba EJ, Meuse L, Kay MA, Calos MP (2001) Epstein-Barr Virus/Human Vector Provides High-Level, Long-Term Expression of alpha (1)-Antitrypsin in Mice. Mol Ther 4:122-129.
62. Sugden B, Warren N (1989) A promoter of Epstein-Barr virus that can function during latent infection can be transactivated by EBNA-1, a viral protein required for viral DNA replication during latent infection. J Virol 63:2644-2649
63. Sun TQ, Fernstermacher DA, Vos JM (1994) Human artificial episomal chromosomes for cloning large DNA fragments in human cells [published erratum appears in Nat Genet 1994 Dec;8(4):410]. Nat Genet 8:33-41
64. Tanaka S, Iwai M, Harada Y, Morikawa T, Muramatsu A, Mori T, Okanoue T, Kashima K, Maruyama-Tabata H, Hirai H, Satoh E, Imanishi J, Mazda O (2000) Targeted killing of carcinoembryonic antigen (CEA)-producing cholangiocarcinoma cells by polyamidoamine dendrimer-mediated transfer of an Epstein-Barr virus (EBV)-based plasmid vector carrying the CEA promoter. Cancer Gene Ther 7:1241-1250
65. Tang MX, Redemann CT, Szoka FC, Jr. (1996) In vitro gene delivery by degraded polyamidoamine dendrimers. Bioconjug Chem 7:703-714
66. Tomiyasu K, Satoh E, Oda Y, Nishizaki K, Kondo M, Imanishi J, Mazda O (1998) Gene transfer in vitro and in vivo with Epstein-Barr virus-based episomal vector results in markedly high transient expression in rodent cells. Biochem Biophys Res Commun 253:733-738
67. Tomiyasu K, Oda Y, Nomura M, Satoh E, Fushiki S, Imanishi J, Kondo M, Mazda O (2000) Direct intra-cardiomuscular transfer of beta2-adrenergic receptor gene augments cardiac output in cardiomyopathic hamsters. Gene Ther 7:2087-2093
68. Vigdal TJ, Kaufman CD, Izsvak Z, Voytas DF, Ivics Z (2002) Common physical properties of DNA affecting target site selection of sleeping beauty and other Tc1/mariner transposable elements. J Mol Biol 323:441-452
69. Vijayanathan V, Thomas T, Thomas TJ (2002) DNA nanoparticles and development of DNA delivery vehicles for gene therapy. Biochemistry 41:14085-14094
70. Westphal EM, Sierakowska H, Livanos E, Kole R, Vos JM (1998) A system for shuttling 200-kb BAC/PAC clones into human cells: stable extrachromosomal persistence and long-term ectopic gene activation. Hum Gene Ther 9:1863-1873
71. Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, Felgner PL (1990) Direct gene transfer into mouse muscle in vivo. Science 247:1465-1468.
72. Wysokenski DA, Yates JL (1989) Multiple EBNA1-binding sites are required to form an EBNA1-dependent enhancer and to activate a minimal replicative origin within oriP of Epstein-Barr virus. J Virol 63:2657-2666
73. Yant SR, Meuse L, Chiu W, Ivics Z, Izsvak Z, Kay MA (2000) Somatic integration and longterm transgene expression in normal and haemophilic mice using a DNA transposon system. Nat Genet 25:35-41
74. Yasutomi K, Itokawa Y, Asada H, Kishida T, Cui FD, Ohashi S, Gojo S, Ueda Y, Kubo T, Yamagishi H, Imanishi J, Takeuchi T, Mazda O (2003) Intravascular insulin gene delivery as potential therapeutic intervention in diabetes mellitus. Biochem Biophys Res Commun 310:897-903
75. Yates JL, Guan N (1991) Epstein-Barr virus-derived plasmids replicate only once per cell cycle and are not amplified after entry into cells. J Virol 65:483-488
76. Zagoraiou L, Drabek D, Alexaki S, Guy JA, Klinakis AG, Langeveld A, Skavdis G, Mamalaki C, Grosveld F, Savakis C (2001) In vivo transposition of Minos, a Drosophila mobile element, in mammalian tissues. Proc Natl Acad Sci U S A 98:11474-11478
77. Zayed H, Izsvak Z, Walisko O, Ivics Z (2004) Development of hyperactive sleeping beauty transposon vectors by mutational analysis. Mol Ther 9:292-304
78. Zayed H, Izsvak Z, Khare D, Heinemann U, Ivics Z (2003) The DNA-bending protein HMGB1 is a cellular cofactor of Sleeping Beauty transposition. Nucleic Acids Res 31:2313-2322